Gul Zartash MD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology, Sickle Cell & Other Anemias

Physician

8081 Innovation Park DrLevel 4 - Skyline ClinicFairfax, VA 22031
Phone+1 571-472-1390
Fax+1 571-472-1391

Dr. Zartash is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zartash's full profile Already have an account?

Summary

Dr. Gul Zartash is a hematologist and based in Fairfax, VA, specializing in cellular therapy including CART and allogeneic stem cell transplant ,hematologic oncology and myeloproliferative disorder , acute leukemias and other myeloid disorders. She graduated from Dow University of Health Sciences in 2001 and has since gained experience in treating conditions such as amyloidosis, myelodysplasia, myelofibrosis, and multiple myeloma. Dr. Zartash is at Inova Schar cancer center as a director of Allogeneic stem cell transplant. She also worked as an adjunct professor at ( university of Wisconsin) advocate Aurora health , Associate Professor and Director of BMT at the University of Cincinnati Medical Center and has previously served as an Assistant Professor at the University of Kentucky Albert B. Chandler Hospital. Her published research includes work on acute graft-versus-host disease prophylaxis and maintenance therapy in multiple myeloma.

Education & Training

Dow University of Health SciencesClass of 2001

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 2023 - 2028
PA State Medical License 2023 - 2026
WI State Medical License 2020 - 2025
WI State Medical License 2020 - 2025
KY State Medical License 2011 - 2022
OH State Medical License 2016 - 2021
WV State Medical License 2018 - 2020
MI State Medical License 2005 - 2012
MI State Medical License 2005 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
ABIMhematology/oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017

Publications & Presentations

PubMed

Refractory Epstein-Barr Virus-Negative Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in a Renal Transplant Patient Treated With Bispecific...
Austin Frisch, Bobby Se, Eric Martin, Haresh Mani, Stephen Medlin
Journal of Medical Cases. 2026-01-01
Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy.
Austin Frisch, Loren Marino, Deena Alsaadi, Aditya Kasarabada, Gwen Hua
Journal of Medical Cases. 2026-01-01
21 citations
Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
Zaid Al-Kadhimi, Zartash Gul, Roberto Rodriguez, Wei Chen, Daryn Smith
Biology of Blood and Marrow Transplantation. 2012-11-01